This scenario suggests that ARID1A‐deficient cells may rely on ARID1B to maintain nuclear levels of BAF complex for their survival.[13, 23, 27] However, further experimental validation, particularly in the context of breast cancer, is necessary to substantiate these findings. This evidence concerns the gene ARID1A and breast carcinoma.